|
|
| Research article summary (published 29 Apr 2008): |
A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy.
Full Abstract
OBJECTIVE: To describe perinatal outcomes of women with pregestational diabetes treated with short-acting, regular insulin and the short-acting insulin analogue, lispro. STUDY DESIGN: This was a prospective observational study of women with pregestational diabetes maintained on short-acting insulin regimens over a 3-year period. Clinical characteristics, aspects of diabetic therapy, and perinatal/neonatal outcomes were collected. RESULTS: Of 107 women, 49 were maintained on regular insulin and 58 utilized the insulin analogue, lispro. Frequency of type 1 diabetes, maternal age, overweight/obese pregravid body mass index (> or =25 kg/m2), preexisting hypertension, and presence of vascular disease were similar between groups. Women treated with lispro had a longer duration of diabetes (11.4 vs. 8.3 years, p = 0.04). Glycemic control was improved in women managed with lispro compared to regular insulin (HgbA1c 5.9 vs. 6.7, p = 0.009). Total insulin requirements were lower in the lispro group in the first (0.58 vs. 0.79 units/kg, p = 0.02), second (0.75 vs. 1.10 units/kg, p = 0.002), and third (0.98 vs. 1.25 units/kg, p = 0.03) trimesters of pregnancy. Mean infant birth weight was greater in the lispro group, whereas the rate of large for gestational age infants and ponderal indices were similar between groups. Malformation rate, gestational age at delivery, neonatal intensive care unit admission, neonatal length of stay, rates of respiratory distress syndrome, and hypoglycemia were similar. CONCLUSIONS: Women treated with lispro demonstrated improved glycemic control and lower total insulin requirements during pregnancy compared to those receiving regular insulin. Perinatal outcomes were similar between women treated with both types of insulin.
Author information
Author/s: Durnwald, Celeste P (CP); Landon, Mark B (MB);
Affiliation: Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, The Ohio State University, Columbus, Ohio 43210, USA.
Journal and publication information
Publication Type: Comparative Study; Journal Article
Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (J Matern Fetal Neonatal Med), published in United States. (Language: eng)
Reference: 2008-May; vol 21 (issue 5) : pp 309-13
Dates: Created 2008/04/30; Completed 2008/10/02;
PMID: 18446657, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus.
30 Dec 2006 - Use of insulin glargine during pregnancy in a type 1 diabetic woman.
30 May 2002 - Pregnant women with type 1 diabetes mellitus treated by glargine insulin.
30 Mar 2006 - Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog).
30 Dec 2002 - Use of insulin glargine during embryogenesis in a pregnant woman with Type 1 diabetes.
30 Aug 2003 - Glargine in pregnant patients with Type 1 diabetes.
30 Dec 2007 - Successful use of insulin glargine during entire pregnancy until delivery in six Type 1 diabetic women.
25 Jun 2006 - Use of glargine insulin before and during pregnancy in a woman with type 1 diabetes and Addison's Disease.
30 Jul 2005 - Importance of observational studies in clinical practice.
30 Dec 2006 - Insulin therapy in diabetes mellitus: how can the currently available injectable insulins be most prudently and efficaciously utilised?
30 Dec 2006
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.